Refractory Transformed B-cell Non-Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13915 | Axicabtagene ciloleucel | 1 | Not Yet Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Not Yet Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Not Yet Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
| DB12498 | Mogamulizumab | 1 / 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB02379 | Beta-D-Glucose | 2 | Active Not Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB00773 | Etoposide | 2 | Active Not Recruiting | 1 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB16371 | Glofitamab | 2 | Active Not Recruiting | 1 |
| DB18115 | Golcadomide | 2 | Not Yet Recruiting | 1 |
| DB09053 | Ibrutinib | 2 | Completed | 1 |
| DB01181 | Ifosfamide | 2 | Active Not Recruiting | 1 |
| DB16582 | Lisocabtagene maraleucel | 2 | Recruiting | 1 |
| DB08935 | Obinutuzumab | 2 | Active Not Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 2 | Active Not Recruiting | 1 |
| DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
| DB15035 | Zanubrutinib | 2 | Recruiting | 2 |